Predictions for the Generic Drug Sector in 2018
PCI Synthesis shares expected trends in the industry within the next year
Posted: January 9, 2018
Contract Pharma published PCI Synthesis’s Predictions for the Generic Drug Sector in 2018. Here are some of the trends that PCI Synthesis shared, which they expect will impact the industry next year
Read the Full Article and watch the video »
Related posts:
3 spring cleaning tips that will do more than declutter
Biotech’s Riding the Polar Express
PCI Announces Four New Proprietary APIs During 2012
Three Questions to Ask Your CMO about Standard Operating Procedures
Continuous Manufacturing is Gaining Steam, but Batch Processing Continues to be a Proven Alternative
About the Author
Ed is President & CEO of SEQENS North America (formerly PCI Synthesis). He serves as a co-chair of the New England CRO/CMO Council and sits on the Industrial Advisory Board for the Department of Chemical Engineering at UMass, Amherst. Ed is also a long standing member of the American Chemical Society and advises the Bulk Pharmaceutical Task Force of the Society of Chemical Manufacturer’s and Affiliates (SOCMA)...